JOHNSON & JOHNSON (1JNJ.MI) Stock Price, Quote, News and Overview
BIT:1JNJ - Borsa Italiana Milan - US4781601046 - Common Stock - Currency: EUR
1JNJ.MI Quote, Performance and Key Statistics
JOHNSON & JOHNSON
BIT:1JNJ (2/3/2025, 7:00:00 PM)
147.32
+2.12 (+1.46%)
The current stock price of 1JNJ.MI is 147.32 EUR. In the past month the price decreased by -1.92%.
1JNJ.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 81.81 | 764.20B | ||
| 1LLY.MI | ELI LILLY & CO | 79.43 | 741.99B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.22 | 413.69B | ||
| NOV.DE | NOVO NORDISK A/S-B | 28.98 | 365.43B | ||
| JNJ.DE | JOHNSON & JOHNSON | 15.25 | 355.12B | ||
| 1SAN.MI | SANOFI | 14.78 | 260.95B | ||
| SAN.PA | SANOFI | 14.61 | 257.81B | ||
| SNW.DE | SANOFI | 14.58 | 257.34B | ||
| 1MRKX.MI | MERCK & CO. INC. | 16.39 | 238.80B | ||
| 6MK.DE | MERCK & CO. INC. | 15.1 | 220.08B | ||
| 1PFE.MI | PFIZER INC | 10.24 | 145.02B | ||
| PFE.DE | PFIZER INC | 10 | 141.65B |
Related stock screener links
About 1JNJ.MI
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 131,900 full-time employees. The firm's primary focus is products related to human health and well-being. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).
Company Info
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick NEW JERSEY US
Employees: 131900
Company Website: https://www.jnj.com/
Investor Relations: https://www.investor.jnj.com
Phone: 17325242455
1JNJ.MI FAQ
What is the stock price of 1JNJ.MI?
The current stock price of 1JNJ.MI is 147.32 EUR.
What is the symbol for JOHNSON & JOHNSON stock?
The exchange symbol of JOHNSON & JOHNSON is 1JNJ and it is listed on the Borsa Italiana Milan exchange.
On which exchange is 1JNJ.MI stock listed?
1JNJ.MI stock is listed on the Borsa Italiana Milan exchange.
Is 1JNJ.MI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for 1JNJ.MI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of 1JNJ.MI.
Does 1JNJ.MI stock pay dividends?
1JNJ.MI has a dividend yield of 3.24%. The yearly dividend amount is currently 4.46.
What is the Price/Earnings (PE) ratio of 1JNJ.MI?
The PE ratio for 1JNJ.MI is 15.23. This is based on the reported non-GAAP earnings per share of 9.67 and the current share price of 147.32 EUR.
1JNJ.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1JNJ.MI.
1JNJ.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1JNJ.MI. 1JNJ.MI has an average financial health and profitability rating.
1JNJ.MI Financial Highlights
Over the last trailing twelve months 1JNJ.MI reported a non-GAAP Earnings per Share(EPS) of 9.67. The EPS decreased by -4.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.74% | ||
| ROA | 8.24% | ||
| ROE | 20.93% | ||
| Debt/Equity | 0.47 |
1JNJ.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to 1JNJ.MI. The Buy consensus is the average rating of analysts ratings from 30 analysts.
For the next year, analysts expect an EPS growth of 6.61% and a revenue growth 2.48% for 1JNJ.MI